TY  - JOUR
AU  - Martín-Izquierdo, Marta
AU  - Abáigar, María
AU  - Hernández-Sánchez, Jesús M
AU  - Tamborero, David
AU  - López-Cadenas, Félix
AU  - Ramos, Fernando
AU  - Lumbreras, Eva
AU  - Madinaveitia-Ochoa, Andrés
AU  - Megido, Marta
AU  - Labrador, Jorge
AU  - Sánchez-Real, Javier
AU  - Olivier, Carmen
AU  - Dávila, Julio
AU  - Aguilar, Carlos
AU  - Rodríguez, Juan N
AU  - Martín-Nuñez, Guillermo
AU  - Santos-Mínguez, Sandra
AU  - Miguel-García, Cristina
AU  - Benito, Rocío
AU  - Díez-Campelo, María
AU  - Hernández-Rivas, Jesús M
PY  - 2021
DO  - 10.3324/haematol.2020.248807
UR  - http://hdl.handle.net/10668/15949
T2  - Haematologica
AB  - Myelodysplastic syndromes (MDS) are hematological disorders at high risk of progression to secondary acute myeloid leukemia (sAML). However, the mutational dynamics and clonal evolution underlying disease progression are poorly understood at present....
LA  - en
KW  - Cell Cycle Proteins
KW  - Chromosomal Proteins, Non-Histone
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - Mutation
KW  - Myelodysplastic Syndromes
KW  - Neoplasms, Second Primary
TI  - Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia.
TY  - research article
VL  - 106
ER  -